These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5810411)

  • 1. [6-azauridine-triacetate in the therapy of chronic polyarthritis].
    Havelka S; Pĕgrímová E; Trnavský K; Slavík M; Elis J
    Z Rheumaforsch; 1969; 28(1):29-35. PubMed ID: 5810411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and hematological observations on patients with rheumatoid arthritis during indomethacin therapy].
    Gáspárdy G; Gáspárdy G; Bálint G; Kemény V
    Z Rheumaforsch; 1966 Jun; 25(5):199-204. PubMed ID: 5997708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral massive dose therapy with Trenimon in progressive chronic polyarthritis (PCP)].
    Prohaska E; Chlud K
    Wien Z Inn Med; 1968; 49(1):26-31. PubMed ID: 5737645
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy with chlorambucil in progressive chronic polyarthritis].
    Thumb N; Horak W
    Wien Z Inn Med; 1968; 49(12):462-70. PubMed ID: 4187786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppresive therapy of progredient chronic polyarthritis using antimetabolites and cytostatics].
    Gross D; Enderlin M; Fehr K
    Schweiz Med Wochenschr; 1967 Oct; 97(40):1301-10. PubMed ID: 4968560
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of progressive chronic polyarthritis with a new cytostatic agent, Imet 3393].
    Wessel G; Rübesamen M; Hesse P
    Dtsch Gesundheitsw; 1971 May; 26(20):919-24. PubMed ID: 5122703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary immune reactions in patients with chronic polyarthritis under cytostatic ("immunosuppressive") therapy].
    Krull P; Fricke R; Wittenborg A; Deicher H
    Z Rheumaforsch; 1972; 31(5):202-9. PubMed ID: 5065469
    [No Abstract]   [Full Text] [Related]  

  • 8. [The copper chelating effect of D-penicillamine in the long-term therapy of progressive chronic polyarthritis].
    Krüger HH
    Med Klin; 1970 Apr; 65(14):650-2. PubMed ID: 4994367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution on the therapy of progressive chronic polyarthritis with antimetabolites and cytostatics].
    Enderlin M; Gross D
    Z Rheumaforsch; 1967 Feb; 26(1):26-35. PubMed ID: 4969230
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of primary chronic polyarthritis with immunosuppressive cytostatic podophyllin derivatives].
    Gömör B; Szántó L; Görgényi F; Benczur M; Ligetiné Reviczky A; Bányai B; Lörincz G
    Orv Hetil; 1969 Jan; 110(4):181-6. PubMed ID: 5779082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythrocytes in the active phase of chronic progressive polyarthritis. I. Red blood count and serum iron level in dependence on the degree of activity].
    Tanner E; Neumann W; Ebner E; Unverricht A; Correns HJ
    Dtsch Gesundheitsw; 1970 Jan; 25(4):144-7. PubMed ID: 5447188
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary report on experience with immunosuppressive therapy in progressive chronic (rheumatoid) polyarthritis and collagen diseases].
    Schuster F; Beier A; Eberl R; Tausch G
    Z Rheumaforsch; 1969; 28(1):12-20. PubMed ID: 5810410
    [No Abstract]   [Full Text] [Related]  

  • 13. Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis.
    Lacki JK; Müller-Ruchholtz W; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):285-8. PubMed ID: 9523002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present status of the treatment of chronic progressive polyarthritis (rheumatoid arthritis) using cytostatics].
    Jesserer H
    Folia Clin Int (Barc); 1968 Feb; 18(2):97-109. PubMed ID: 5735139
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term clinical follow-up studies of basic therapy in rheumatoid arthritis].
    Piaĭ LT
    Ter Arkh; 1981; 53(7):67-9. PubMed ID: 7292319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of the cellular and humoral immune response in rheumatoid polyarthritis].
    Duţu A; Popescu MR; Rusu ML; Părău N; Urcan S; Radu D; Coldea A; Dejica D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(5):461-7. PubMed ID: 6134323
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical aspects of the use of cytostatic substances in rheumatoid arthritis].
    Benenson EV; Levin AI
    Ter Arkh; 1973 Jan; 45(1):45-50. PubMed ID: 4770020
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leucocyte agglomeration as an activity criterion of progressive chronic polyarthritis].
    Fischer H
    Z Arztl Fortbild (Jena); 1971 Aug; 65(15):784-7. PubMed ID: 5143490
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the pathophysiology of cytostatic therapy in primary chronic polyarthritis].
    Gerlach U
    Verh Dtsch Ges Inn Med; 1968; 74():1098-102. PubMed ID: 5714246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complement system in patients with rheumatoid arthritis related to administered drug therapy].
    Kozlov DV; Kudriashova LP; Ivanova IV
    Klin Med (Mosk); 1994; 72(5):43-7. PubMed ID: 7853815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.